SCHEMBL18609595

SCHEMBL18609595

CNC(=O)c1ccc(COc2ccccc2CNC(=O)Nc2cc(OC(F)(F)F)ccc2OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.49
HDAC1 Q13547 2/20 0.47
HDAC6 Q9UBN7 2/20 0.47
HDAC11 Q96DB2 1/20 0.47
PLA2G1B P04054 1/20 0.46
ATG4B Q9Y4P1 1/20 0.46
PPARG P37231 2/20 0.45
PPARD Q03181 2/20 0.45
PPARA Q07869 2/20 0.45
KMT2A Q03164 2/20 0.44
NPC1 O15118 2/20 0.44
CASP3 P42574 2/20 0.44
RAB9A P51151 2/20 0.44
SENP7 Q9BQF6 2/20 0.44
KDM4E B2RXH2 2/20 0.44
MEN1 O00255 1/20 0.44
HPGD P15428 1/20 0.44
LMNA P02545 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18609408 0.92 L3MBTL1 (0.52) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B
SCHEMBL18609596 0.92 L3MBTL1 (0.47) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B
SCHEMBL18609825 0.92 RXRA (0.53) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B
SCHEMBL18609826 0.91 HDAC1 (0.56) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B
SCHEMBL20357398 0.90 L3MBTL1 (0.43) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B
SCHEMBL18609828 0.89 L3MBTL1 (0.48) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B
SCHEMBL18609814 0.89 ALOX5 (0.49) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B
SCHEMBL18609598 0.88 MCHR1 (0.51) L3MBTL1HDAC1HDAC6HDAC11PPARG
SCHEMBL18609585 0.87 ALDH1A1 (0.49) L3MBTL1PLA2G1BATG4BKMT2ASMN1; SMN2
SCHEMBL20608399 0.87 MTNR1B (0.44) L3MBTL1HDAC1HDAC6HDAC11PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190010117-A1 UREA DERIVATIVE AND USE THEREFOR TORAY INDUSTRIES, INC. (JP) 2019-01-10 US disclosed
EP-3345892-A1 UREA DERIVATIVE AND USE THEREFOR Toray Industries, Inc. (JP) 2018-07-11 EP disclosed
EP-3345892-A1 UREA DERIVATIVE AND USE THEREFOR Toray Industries, Inc. (JP) 2018-07-11 EP disclosed
WO-2017038871-A1 UREA DERIVATIVE AND USE THEREFOR 東レ株式会社 2017-03-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190010117-A1 UREA DERIVATIVE AND USE THEREFOR UTS2R, SLC14A1, TMEM164 L3MBTL1 3000/4885HDAC1 1681/4885HDAC6 2385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.